
Pro-Dex PDEX
$ 42.14
-2.86%
Annual report 2025
added 09-04-2025
Pro-Dex DPO Ratio 2011-2025 | PDEX
Annual DPO Ratio Pro-Dex
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.4 | 31.5 | 33 | 38.2 | 31.7 | 33.3 | 41.9 | 27.2 | 28.7 | 20.8 | 70.4 | 34.6 | 36.1 | 19.5 | 26.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.4 | 19.5 | 33.9 |
Quarterly DPO Ratio Pro-Dex
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.8 | 39.4 | 41.9 | - | 28.1 | 26.3 | 27.6 | - | 31.7 | 36.4 | 41 | 19.8 | 41.6 | 32.3 | 33.1 | 15.7 | 29.5 | 34.6 | 33.9 | 31.6 | 32.4 | 27.3 | 34.5 | 35.7 | 30.3 | 23.8 | 24.8 | 23.8 | 21.9 | 22.1 | 29 | 27.5 | 26.5 | 27 | 24.9 | 23.3 | 25.5 | 29.9 | 46.2 | 43.7 | 40.5 | 31.5 | 35.1 | 32.4 | 35.4 | 24.2 | 37.6 | 36.8 | 40.2 | 38.9 | 35.7 | 29.3 | 46.3 | 45.9 | 36.8 | 31.4 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 46.3 | 15.7 | 32.4 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
130 | $ 24.39 | - | $ 1.12 B | ||
|
Baxter International
BAX
|
50.7 | $ 19.68 | 2.77 % | $ 10 B | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 200.26 | -0.34 % | $ 57.6 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
73.7 | $ 4.68 | 0.21 % | $ 94.4 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
47.4 | $ 0.71 | -3.6 % | $ 30.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
34.9 | $ 147.79 | -0.43 % | $ 3.6 B | ||
|
Alcon
ALC
|
63.6 | $ 79.23 | 0.53 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
12.6 | $ 171.52 | 1.59 % | $ 5.35 B | ||
|
AtriCure
ATRC
|
81.2 | $ 41.41 | -2.29 % | $ 1.94 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
279 | $ 4.8 | 1.05 % | $ 26.5 K | ||
|
Repro Med Systems
KRMD
|
52 | $ 5.8 | 0.35 % | $ 264 M | ||
|
AngioDynamics
ANGO
|
96.2 | $ 13.38 | 1.83 % | $ 547 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 81.12 | -1.17 % | $ 16.2 B | ||
|
LeMaitre Vascular
LMAT
|
14.5 | $ 83.58 | -0.5 % | $ 1.88 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 111.86 | 2.72 % | $ 5.42 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 78.81 | -5.6 % | $ 3.97 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 9.18 | -0.65 % | $ 190 M | ||
|
Masimo Corporation
MASI
|
84.4 | $ 136.6 | -1.25 % | $ 7.28 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Merit Medical Systems
MMSI
|
34.4 | $ 85.98 | -0.83 % | $ 5.01 B | ||
|
Intuitive Surgical
ISRG
|
25.7 | $ 554.57 | 2.26 % | $ 197 B | ||
|
OraSure Technologies
OSUR
|
36.6 | $ 2.48 | -0.25 % | $ 185 M | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.25 | -6.64 % | $ 22.9 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.37 | -5.12 % | $ 29.5 M | ||
|
Nephros
NEPH
|
50.5 | $ 4.96 | -1.29 % | $ 51.5 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
56.8 | $ 22.01 | 0.16 % | $ 3.79 B | ||
|
ResMed
RMD
|
34.9 | $ 252.48 | 0.05 % | $ 36.9 B | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 23.59 | -2.24 % | $ 1.16 B | ||
|
STERIS plc
STE
|
31.8 | $ 252.72 | 0.32 % | $ 24.9 B | ||
|
Stereotaxis
STXS
|
99 | $ 2.36 | -0.42 % | $ 190 M | ||
|
Pulse Biosciences
PLSE
|
68.4 | $ 14.04 | -1.44 % | $ 674 M | ||
|
Predictive Oncology
POAI
|
547 | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 158.66 | 0.81 % | $ 8.84 M | ||
|
Utah Medical Products
UTMD
|
18 | $ 58.21 | 0.19 % | $ 211 M | ||
|
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.38 | -1.69 % | $ 2.31 B | ||
|
Retractable Technologies
RVP
|
48.6 | $ 0.84 | 2.04 % | $ 25.1 M | ||
|
Teleflex Incorporated
TFX
|
37.1 | $ 126.36 | -0.24 % | $ 5.92 B | ||
|
West Pharmaceutical Services
WST
|
46.4 | $ 270.21 | 0.99 % | $ 19.7 B |